InMode Ltd’s Revenue Breakdown Worldwide (2018-2022)

These statistics highlight InMode Ltd’s Revenue Breakdown Worldwide starting, split into US and International, reported quarterly from 2018 onwards.

InMode Ltd’s Revenue Breakdown Worldwide:

Inmode Ltd, formerly known as Invasix Ltd, is an Israel-based company founded in 2008, which is a global provider of innovative and modern medical technologies. InMode designs manufactures, and sells devices that use novel radio-frequency (RF) technology to enable new surgical procedures and improve existing treatments. The products and solutions offered by Inmode Ltd are primarily intended to address three energy-based treatment categories: face and body contouring, medical aesthetics, and women’s health. The company has major business with 69 countries and more.

The Revenue Breakdown by Geography of Inmode Ltd can be split into:

1. US
2. International

(All values are in USD millions, except percentages)

Revenue earned by Inmode Ltd can be split into – US and International. In the quarter 2022 Q1, Inmode Ltd made 37.6% from the US market and 62.4% from the international market. In the case of an international market, Inmode Ltd is allowed to sell its products in most countries in North America, Europe, Asia, Africa, Asia Pacific, and Latin America. The company directly sells its products in the United States, Canada, United Kingdom, Spain, Portugal, France, Belgium, Luxembourg, Italy, Australia, and India. Besides them, Inmode Ltd also sells its products to 69 countries across the world.

The overall revenue has dropped in 2022 Q1 by 22.2 % when compared with the previous quarter. The drop in the total revenue is because of the comparatively low revenue earned in the international market, although the US market has performed equally well when compared with the other quarters. The International revenue of Inmode Ltd has dropped by 27.7 % in 2022 Q1, which seems to have affected the total revenue. The 2021 Q4 has had the highest revenue both in terms of international and US markets. The range for the above table is 24,619 million with 2021 Q4 being the highest and 2022 Q1 being the lowest.

About InMode Ltd:

Inmode Ltd, formerly Invasix Ltd, is an Israel-based company that was founded in 2008 and is a global provider of innovative and cutting-edge medical technologies. InMode develops, manufactures, and sells medical devices that make use of novel radio-frequency (RF) technology to enable new surgical procedures and improve existing treatments. Inmode Ltd’s products and solutions are primarily aimed at three energy-based treatment categories: face and body contouring, medical aesthetics, and women’s health.

Physicians use these technologies to remodel subdermal adipose or fatty tissue, in a variety of procedures such as liposuction with concurrent skin tightening, face and body contouring, ablative skin rejuvenation treatments, and treatment of Genitourinary Syndrome of Menopause (GSM). Their products, developed with their proprietary RF energy-based technologies, overcome many of the shortcomings of other surgical options by delivering surgical-grade results under local anaesthesia while significantly reducing the risks of scarring, downtime, pain, and other complications that are typically associated with surgical procedures. Aside from minimally invasive solutions, the company designs develop, manufactures, and markets differentiated, non-invasive medical aesthetic products for a wide range of procedures.

Did you like InMode Ltd’s Revenue Breakdown Worldwide statistic?

Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.

You can get started here.